相关实验视频

Updated: Jan 18, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

美国新生儿查的关键时刻

Journal of obstetric, gynecologic, and neonatal nursing : JOGNN

|September 8, 2025

概括

新生儿和儿童遗传性疾病咨询委员会 (ACHDNC) 被淘汰,留下了一个审查新生儿查条件的空白. 本分析探讨了政策解决方案和护士在塑造未来新生儿查协议中的作用.

科学领域:

公共卫生政策公共卫生政策
遗传学和基因组学遗传学和基因组学
医疗保健管理部门的管理.

背景情况:

新生儿和儿童遗传性疾病咨询委员会 (ACHDNC) 是国家新生儿查的关键机构,于2025年4月被HHS取消.
ACHDNC负责评估科学证据,并推全国新生儿查的新条件和政策.
它的缺席在审查和推新条件被纳入新生儿查小组的正式过程中造成了空白.

研究的目的:

检查 ACHDNC 的终止对国家新生儿查系统的影响.
探索潜在的政策途径,以解决条件审查和建议方面的差距.
突出护士在倡导和塑造新生儿查政策方面的作用.

主要方法:

对消除ACHDNC的影响进行政策分析.
审查新审查流程的拟议模型,包括国家科学院,工程院和医学院的建议.
考虑HHS当前的重组,包括优先事项的转变和预算讨论.

主要成果:

终止ACHDNC已经取消了对新生儿查条件的科学审查和建议的建立机制.
当前HHS内部的医疗保健政策格局正在发生重大变化,这可能会影响新查协议的开发.
护士被确定为关键利益相关者,他们可以影响新生儿查政策的未来方向.

结论:

消除ACHDNC需要开发替代的正式流程,以确保新生儿查的持续改进.
政策解决方案,如国家学院提出的,需要仔细考虑,以填补现有的空白.
通过倡导,合作和教育,护士积极参与,对于导航这些政策变化和加强新生儿查系统至关重要.

关键词:

咨询委员会咨询委员会遗传病是一种遗传性疾病.卫生政策卫生政策遗传代谢性疾病是天生的代谢性疾病.新生儿查新生儿查公共卫生公共卫生.

更多相关视频

State of the Art Cranial Ultrasound Imaging in Neonates

State of the Art Cranial Ultrasound Imaging in Neonates

Published on: February 2, 2015

Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR

Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR

Published on: December 6, 2014

相关概念视频

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

Drug Dosing: Infants and Children

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...